CSS LLC’s Bristol-Myers Squibb BMY Stock Holding History

CSS LLC’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-15,000	Closed	-$1.16M	–	1060
2022 Q2	$1.16M	Buy	+15,000	New	+$1.14M	0.05%	396
2020 Q1	–	Sell	-57,800	Closed	-$3.68M	–	632
2019 Q4	$3.68M	Buy	57,800 +10,700	+23%	+$613K	0.2%	102
2019 Q3	$2.39M	Buy	+47,100	New	+$2.21M	0.15%	117

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

CSS LLC's BMY Position: Q2 2026 in Review

CSS LLC increased its Bristol-Myers Squibb (BMY) stake by 34% in Q2 2026, buying an estimated $472K and bringing the position to 32,320 shares worth $1.86M. The position accounts for 0.07% of the portfolio, ranked #192.

CSS LLC first reported a position in BMY in Q4 2019 and has held it in 27 quarters since. The position peaked at $3.27M in Q4 2019. 2,523 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

CSS LLC held 32,320 shares of Bristol-Myers Squibb worth $1.86M as of Q2 2026.
CSS LLC bought 8,220 Bristol-Myers Squibb shares in Q2 2026, an estimated $472K.
Bristol-Myers Squibb made up 0.07% of CSS LLC's portfolio in Q2 2026, its #192 holding.
CSS LLC first reported a position in Bristol-Myers Squibb in Q4 2019 and has held it in 27 quarters since.
CSS LLC's Bristol-Myers Squibb position peaked at $3.27M in Q4 2019.
2,523 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on CSS LLC's 13F filing for Q2 2026, filed 14 Aug 2026.